Timothy Mullett, MD, leaned toward his computer screen as he spoke, drowning out the sounds of the busy coffee shop behind him to get his message across.

Cancer is the second leading cause of death in the U.S., but research shows that at least 42% of new cancer cases are ...

The firms aim to use Azure AI to process clinical notes, lab tests, genomic data, images, and other often inaccessible data to identify personalized treatments.

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

October is widely recognized as Breast Cancer Awareness Month. Often symbolized by the pink ribbon, St. Anthony Regional ...

A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...

Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...

It sometimes develops due to lung problems, like respiratory infections, blood clots, or lung cancer. What feels like lung pain may also originate in a nearby structure, such as the chest wall or ...